Alzheimer's Disease Brain-Derived Amyloid-β-Mediated Inhibition of LTP In Vivo Is Prevented by Immunotargeting Cellular Prion Protein

被引:201
作者
Barry, Andrew E. [1 ,2 ]
Klyubin, Igor [1 ,2 ]
Mc Donald, Jessica M. [3 ]
Mably, Alexandra J. [3 ]
Farrell, Michael A. [4 ]
Scott, Michael [3 ]
Walsh, Dominic M. [3 ]
Rowan, Michael J. [1 ,2 ]
机构
[1] Trinity Coll Dublin, Dept Pharmacol & Therapeut, Dublin 2, Ireland
[2] Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland
[3] Univ Coll Dublin, Conway Inst, Lab Neurodegenerat Res, Sch Biomol & Biomed Sci, Dublin 4, Ireland
[4] Beaumont Hosp, Dept Pathol, Dublin 9, Ireland
基金
爱尔兰科学基金会;
关键词
SYNAPTIC PLASTICITY; RECEPTOR; OLIGOMERS; MEMORY; IMPAIRMENT; BINDING; HIPPOCAMPUS; DIMERS; STATE;
D O I
10.1523/JNEUROSCI.6500-10.2011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Synthetic amyloid-beta protein (A beta) oligomers bind with high affinity to cellular prion protein (PrPC), but the role of this interaction in mediating the disruption of synaptic plasticity by such soluble A beta in vitro is controversial. Here we report that intracerebroventricular injection of A beta-containing aqueous extracts of Alzheimer's disease (AD) brain robustly inhibits long-term potentiation (LTP) without significantly affecting baseline excitatory synaptic transmission in the rat hippocampus in vivo. Moreover, the disruption of LTP was abrogated by immunodepletion of A beta. Importantly, intracerebroventricular administration of antigen-binding antibody fragment D13, directed to a putative A beta-binding site on PrPC, prevented the inhibition of LTP by AD brain-derived A beta. In contrast, R1, a Fab directed to the C terminus of PrPC, a region not implicated in binding of A beta, did not significantly affect the A beta-mediatedinhibition of LTP. These data support the pathophysiological significance of SDS-stable A beta dimer and the role of PrPC in mediating synaptic plasticity disruption by soluble A beta.
引用
收藏
页码:7259 / 7263
页数:5
相关论文
共 35 条
[21]  
2-M
[22]   Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus [J].
Puzzo, Daniela ;
Privitera, Lucia ;
Leznik, Elena ;
Fa, Mauro ;
Staniszewski, Agnieszka ;
Palmeri, Agostino ;
Arancio, Ottavio .
JOURNAL OF NEUROSCIENCE, 2008, 28 (53) :14537-14545
[23]   Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5 [J].
Renner, Marianne ;
Lacor, Pascale N. ;
Velasco, Pauline T. ;
Xu, Jian ;
Contractor, Anis ;
Klein, William L. ;
Triller, Antoine .
NEURON, 2010, 66 (05) :739-754
[24]   Alzheimer's disease is a synaptic failure [J].
Selkoe, DJ .
SCIENCE, 2002, 298 (5594) :789-791
[25]  
Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
[26]   Alzheimer's disease: synaptic dysfunction and Aβ [J].
Shankar, Ganesh M. ;
Walsh, Dominic M. .
MOLECULAR NEURODEGENERATION, 2009, 4
[27]   DIFFERENTIAL BINDING OF VASCULAR CELL-DERIVED PROTEOGLYCANS (PERLECAN, BIGLYCAN, DECORIN, AND VERSICAN) TO THE BETA-AMYLOID PROTEIN OF ALZHEIMERS-DISEASE [J].
SNOW, AD ;
KINSELLA, MG ;
PARKS, E ;
SEKIGUCHI, RT ;
MILLER, JD ;
KIMATA, K ;
WIGHT, TN .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 320 (01) :84-95
[28]   β-amyloid1-42 binds to α7 nicotinic acetylcholine receptor with high affinity -: Implications for Alzheimer's disease pathology [J].
Wang, HY ;
Lee, DHS ;
D'Andrea, MR ;
Peterson, PA ;
Shank, RP ;
Reitz, AB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5626-5632
[29]   The levels of soluble versus insoluble brain Aβ distinguish Alzheimer's disease from normal and pathologic aging [J].
Wang, J ;
Dickson, DW ;
Trojanowski, JQ ;
Lee, VMY .
EXPERIMENTAL NEUROLOGY, 1999, 158 (02) :328-337
[30]   Mapping the prion protein using recombinant antibodies [J].
Williamson, RA ;
Peretz, D ;
Pinilla, C ;
Ball, H ;
Bastidas, RB ;
Rozenshteyn, R ;
Houghten, RA ;
Prusiner, SB ;
Burton, DR .
JOURNAL OF VIROLOGY, 1998, 72 (11) :9413-9418